A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )

Clinical trial NCT04221152 · UNKNOWN

Trial details

NCT number: NCT04221152
Sponsor: Kobe University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Insulin Resistance - Type A Insulin Resistance - Type B Lipoatrophic Diabetes Mellitus Insulin Resistance Syndrome

Start date: 2020-02-01
Primary completion: 2022-02-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.